IXJ ETF Analysis: Global Healthcare | NYSE
Health | NYSE, USA | Market Cap: 3.706m USD | 12M Return: 15.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.5M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares Global Healthcare ETF (IXJ) is a passively managed exchange-traded fund that tracks an underlying index composed of companies classified within the global healthcare sector by S&P Dow Jones Indices. The fund adheres to a standard index-tracking structure, investing at least 80% of its assets in the securities that make up its benchmark index, with the remaining portion permitted in derivatives such as futures, options, and swap contracts, as well as cash and cash equivalents. The 80% policy is a regulatory convention for funds marketed as tracking a specific index.
Launched in November 2001, IXJ provides exposure to healthcare equities across global markets, a sector that typically spans pharmaceuticals, biotechnology, medical devices, and healthcare services providers. As a mid-cap ETF with approximately $3.7 billion in assets, it offers investors a vehicle to participate in the performance of large and mid-sized healthcare companies considered significant to international markets by the index provider.
- Medicare drug price negotiations expand to more drugs
- Aging global population drives sustained healthcare demand
- Blockbuster drug patent cliffs pressure pharma revenue
As of July 24, 2026, the stock is trading at USD 99.29 with a total of 300,193 shares traded. Over the past week, the price has changed by -0.38%, over one month by +4.69%, over three months by +7.40% and over the past year by +15.42%.
Current recommended Stop Loss: 96.50 (which is 2.8% or 1.9 ATR below the current price).
Global Healthcare has no consensus analysts rating.